Evidence map›Paper›PMID 34166609›Full record

ArticleMolecular cell2021

Nascent RNA antagonizes the interaction of a set of regulatory proteins with chromatin.

Lenka Skalska, Victoria Begley, Manuel Beltran, Saulius Lukauskas, Garima Khandelwal, Peter Faull, Amandeep Bhamra, Manuel Tavares, Rachel Wellman, Andrey Tvardovskiy and 7 more

Open access · greenAbstract read
PubMed Publisher
In one paragraph

Article in Molecular cell, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
2.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 39 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. PRC2 direct transfer from G-quadruplex RNA to dsDNA has implications for RNA-binding chromatin modifiers.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors at 4 institutions in 2 countries.

Lenka SkalskaUCL Cancer Institute and Cancer Research UK UCL Centre, University College London (UCL), London WC1E 6BT, UK.
Victoria BegleyUCL Cancer Institute and Cancer Research UK UCL Centre, University College London (UCL), London WC1E 6BT, UK.
Manuel BeltranUCL Cancer Institute and Cancer Research UK UCL Centre, University College London (UCL), London WC1E 6BT, UK.
Saulius LukauskasInstitute of Functional Epigenetics, Helmholtz Zentrum München, Neuherberg 85764, Germany.
Garima KhandelwalUCL Cancer Institute and Cancer Research UK UCL Centre, University College London (UCL), London WC1E 6BT, UK.
Peter FaullThe Francis Crick Institute, London NW1 1AT, UK.
Amandeep BhamraProteomics Research Translational Technology Platform, UCL Cancer Institute and Cancer Research UK UCL Centre, University College London (UCL), London WC1E 6BT, UK.
Manuel TavaresUCL Cancer Institute and Cancer Research UK UCL Centre, University College London (UCL), London WC1E 6BT, UK.
Rachel WellmanUCL Cancer Institute and Cancer Research UK UCL Centre, University College London (UCL), London WC1E 6BT, UK.
Andrey TvardovskiyInstitute of Functional Epigenetics, Helmholtz Zentrum München, Neuherberg 85764, Germany.
Benjamin M FosterInstitute of Functional Epigenetics, Helmholtz Zentrum München, Neuherberg 85764, Germany.
Igor Ruiz de Los MozosThe Francis Crick Institute, London NW1 1AT, UK; Institute of Neurology, UCL, London WC1N 3BG, UK.
Javier HerreroUCL Cancer Institute and Cancer Research UK UCL Centre, University College London (UCL), London WC1E 6BT, UK.
Silvia SurinovaProteomics Research Translational Technology Platform, UCL Cancer Institute and Cancer Research UK UCL Centre, University College London (UCL), London WC1E 6BT, UK.
Ambrosius P SnijdersThe Francis Crick Institute, London NW1 1AT, UK.
Till BartkeInstitute of Functional Epigenetics, Helmholtz Zentrum München, Neuherberg 85764, Germany.
Richard G JennerUCL Cancer Institute and Cancer Research UK UCL Centre, University College London (UCL), London WC1E 6BT, UK. Electronic address: r.jenner@ucl.ac.uk.
Cancer Research UK · GBUniversity College London · GBHelmholtz Zentrum München · DEThe Francis Crick Institute · GB

Funding

Cancer Research UK C33499/A20265Cancer Research UK C416/A25145Worldwide Cancer Research 21-0255
6 · The paper itself

Abstract

A number of regulatory factors are recruited to chromatin by specialized RNAs. Whether RNA has a more general role in regulating the interaction of proteins with chromatin has not been determined. We used proteomics methods to measure the global impact of nascent RNA on chromatin in embryonic stem cells. Surprisingly, we found that nascent RNA primarily antagonized the interaction of chromatin modifiers and transcriptional regulators with chromatin. Transcriptional inhibition and RNA degradation induced recruitment of a set of transcriptional regulators, chromatin modifiers, nucleosome remodelers, and regulators of higher-order structure. RNA directly bound to factors, including BAF, NuRD, EHMT1, and INO80 and inhibited their interaction with nucleosomes. The transcriptional elongation factor P-TEFb directly bound pre-mRNA, and its recruitment to chromatin upon Pol II inhibition was regulated by the 7SK ribonucleoprotein complex. We postulate that by antagonizing the interaction of regulatory proteins with chromatin, nascent RNA links transcriptional output with chromatin composition.

Indexed as

AnimalsChromatinDNA-Binding ProteinsEmbryonic Stem CellsGene Expression RegulationHEK293 CellsHumansMaleMiceNucleosomesPositive Transcriptional Elongation Factor BProtein BindingProteomicsRNARNA Polymerase IITranscriptional Elongation FactorsChromatinDNA-Binding ProteinsNucleosomesPositive Transcriptional Elongation Factor BRNARNA Polymerase IITranscriptional Elongation FactorsTranscription Factorschromatinhistone modificationnascent RNAnucleosomenucleosome remodellerpre-mRNARNA polymerase IIRNAsetranscriptional elongationtranscription factor

Identifiers

PMID34166609
OpenAlexW3172438350

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.